glucarpidase
Eurogentec
[]
congress | #esmo22 | poster adolfo de la fuente burguera presented a phase ii trial design of glucarpidase in patients with r/r dlbcl at high risk of cns relapse #lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm